Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8

8 clinical trials · Condition

Record	Firm	Date
A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study (NCT07517211)	Jonsson Comprehensive Cancer Center	2026-12-01
Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial (NCT07439484)	Jonsson Comprehensive Cancer Center	2026-09-01
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence (NCT07139951)	Mayo Clinic	2025-12-03
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer (NCT05836584)	National Cancer Institute (NCI)	2023-12-06
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma (NCT06078709)	Mayo Clinic	2023-11-20
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer (NCT04929392)	City of Hope Medical Center	2022-01-25
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer (NCT03801876)	NRG Oncology	2019-06-26
Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer (NCT03776487)	M.D. Anderson Cancer Center	2019-01-07

Every clearance here is in the API, with alerts when new ones post.